Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 56 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle Cell Lymphoma Ahead of key Competitiveness Council Meeting of European Research Ministers, ESMO calls for measures supporting a robust clinical research ecosystem in Europe that enables... EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib MOST POPULAR Adding Tafasitamab to Lenalidomide and Rituximab Prolongs PFS in Patients with... December 18, 2025 Can Acupuncture Help Cancer Survivors with Chronic Pain? April 22, 2021 Is there a future without Pap testing? October 21, 2020 Doctor Said Her Mammogram Results Were Normal, But Now She’s Fighting... August 25, 2020 Load more HOT NEWS How do we die of cancer? What we know (and what... FDA Approves Toripalimab-tpzi for Nasopharyngeal Carcinoma PDX Mouse Models Are Reliable Stand-Ins for Human Tumors, Study Finds Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer
